↓ Skip to main content

Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders

Overview of attention for article published in Frontiers in immunology, July 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
12 Mendeley